NHS National Pharmaceuticals Transition 2022_1

NHS England · Awarded

Buyer
NHS England
Status
Awarded
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-032338
Published
2022-08-12
Deadline
2026-04-30

Tender summary

NHS National Pharmaceuticals Transition 2022_1 Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap